Human Chitinase-3-like Protein 1(YKL-40/CHI3L1)ELISA Kit
-
中文名稱:
人幾丁質酶3樣蛋白1(YKL-40/CHI3L1)酶聯免疫試劑盒
-
貨號:
CSB-E13608h
-
樣本類型:
serum, plasma, tissue homogenates
-
檢測范圍:
46.875 pg/mL-3000 pg/mL
-
靈敏度:
78.065 pg/mL
-
規格:
96T/48T
-
價格:
¥3600/¥2500
-
促銷:
-
其他:
引用文獻
-
The association of serum CHI3L1 levels with the presence of Kawasaki disease
J Zou, X He, W Li, Y Duan, B Liu, J Jiang, D Luo,Scientific Reports,2025
-
Identification of a Novel Serum Biomarker for Tuberculosis Infection in Chinese HIV Patients by iTRAQ-Based Quantitative Proteomics
Chen C,Frontiers in microbiology,2023
-
Low expression of lncRNA UCA1 assists the diagnosis of type 2 diabetes mellitus and predicts an increased risk of cardiovascular complications
H Yuan,All Life,2022
-
Cell-free mitochondrial DNA in progressive multiple sclerosis
Hannah Lowes .et al,Mitochondrion,2018
-
Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
Wang J.et al,Respir Res.,2018
-
Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome
Bak謀rc謀 EM.et al,Turk Kardiyol Dern Ars.,2015
-
Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer´s Disease
Hong-Ri Zhang. et al,Neurochemical Research,2015
產品評價
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:3
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的含量,檢測結果標準品從S0-S7的OD值分別為0.1553,0.2041,0.2738,0.4769,0.8855,1.7417,2.9027,3.899。對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml。本次檢測樣本的OD值大部分在2.5-4之間,需要提高樣品稀釋度
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:3.2
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的濃度,本次檢測標準品的吸光度從S0-S7分別為0.0466,0.0643,0.2327,0.4275,1.1812,1.7124,2.0805,3.9801對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
標準曲線上沒有S6這個點,因為有偏移,所以把這部分數據去掉,重新擬合了曲線。
本次檢測樣本濃度太高了,OD值偏高,大部分在3-4這個范圍,所以下次打算增加稀釋倍數到1:6
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:7
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的濃度,檢測結果標準品的OD值分別為0.1263,0.1823,0.2474,0.4418,0.8466,1.6282,2.7948,3.6766對應的標準品濃度分別為是0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次稀釋比例約為1:7,稀釋后樣本的OD值分布在0.3-3.8之間,提高稀釋度后檢測結果可能會更準確
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:7
產品評價: 我用CSB-E13608h檢測了人血漿YKL-40的濃度,檢測結果標準品OD值分別為0.1453,0.2392,0.4243,0.7651,1.4275,2.4159,3.4856對應的標準品濃度分別為46.875,93.75,187.5,375,750,1500,3000pg/ml
本次檢測的樣品OD值范圍在0.0888-4之間
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:6
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的濃度,檢測結果標準品OD值分別為0.0864,0.1365,0.2306,0.4222,0.8016,1.4808,2.3606,3.2313對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次檢測樣品的OD值在0.5817-4之間
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:7
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的濃度,檢測結果標準品的OD值分別為0.0999,0.1734,0.2846,0.5755,1.1967,2.2888,3.4592,3.9755。對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次提交的曲線沒有S6 3.4592 1500pg/ml這個點,因為加上這個點之后曲線的誤差太大。
本次檢測樣品的OD值位于1-4之間,部分達到了4,稀釋度可以繼續提高
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:8
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的濃度,檢測結果標準品的OD值分別為0.108,0.1412,0.1919,0.3528,0.7337,1.4657,2.3068,3.6037。分別對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次檢測樣品的OD值范圍在0.3795-4之間,稀釋度可以適當提高一點
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:8
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的濃度,檢測結果標準品OD值分別為0.172,0.269,0.367,0.658,1.273,2.108,3.132,3.986,對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次檢測樣品的OD值范圍在0.52-4之間,有兩個樣品的吸光度超過了4,所以下次可以再稀釋這兩個樣本。
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:9
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的含量,檢測結果標準品從S1-S7的OD值分別為0.0876,0.1616,0.2832,0.5379,1.1642,2.0419,3.2661,3.9086對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次檢測加入稀釋液265ul,血漿體積為20-35ul
檢測樣本吸光度在0.4151-4之間,高濃度的樣本可以繼續稀釋
樣品類型:血漿(抗凝劑) EDTA
樣品信息:人
稀釋比:其他 1:9
產品評價: 我用CSB-E13608h檢測了人血漿中YKL-40的含量,檢測結果標準品從S0-S7的OD值分別為0.0892,0.1622,0.2873,0.5475,1.1817,2.108,3.132,3.8731。對應的標準品濃度分別為0,46.875,93.75,187.5,375,750,1500,3000pg/ml
本次檢測的樣品OD值范圍在0.4117-4之間,有4個OD值為4,還需要繼續稀釋
靶點詳情
-
最新研究進展:
CHI3L1(也稱為YKL-40)是一種由人類chitinase 3-like 1基因編碼的蛋白質。CHI3L1在炎癥和纖維化反應中發揮重要作用。最近的研究表明,CHI3L1與多種疾病的發病機制有關,如關節炎、哮喘、慢性阻塞性肺疾病、肝病和癌癥等。此外,CHI3L1在心臟病和腦卒中等心腦血管疾病中的潛在作用也被越來越多的研究所關注。
-
功能:
Carbohydrate-binding lectin with a preference for chitin. Has no chitinase activity. May play a role in tissue remodeling and in the capacity of cells to respond to and cope with changes in their environment. Plays a role in T-helper cell type 2 (Th2) inflammatory response and IL-13-induced inflammation, regulating allergen sensitization, inflammatory cell apoptosis, dendritic cell accumulation and M2 macrophage differentiation. Facilitates invasion of pathogenic enteric bacteria into colonic mucosa and lymphoid organs. Mediates activation of AKT1 signaling pathway and subsequent IL8 production in colonic epithelial cells. Regulates antibacterial responses in lung by contributing to macrophage bacterial killing, controlling bacterial dissemination and augmenting host tolerance. Also regulates hyperoxia-induced injury, inflammation and epithelial apoptosis in lung.
-
基因功能參考文獻:
- YKL-40 elevation significantly improved risk prediction for all-cause and cardiovascular mortality in hemodialysis patients. PMID: 28941940
- Polymorphisms of the CHI3L1 gene (rs4950928 C>G and rs10399931 C>T) are associated with the risk and prognosis of AD and can affect the expression of CHI3L1 in plasma. PMID: 30223258
- High YKL-40 expression is associated with endothelial cell angiogenesis in breast cancer. PMID: 29274508
- Pretreatment serum levels of YKL-40 may be a novel prognostic factor of overall and disease-free survival in patients with nonmetastatic colorectal cancer PMID: 29642772
- Plasma YKL-40 distinguishes between patients with features of asthma-chronic obstructive pulmonary disorder (COPD) overlap (ACO) and COPD patients. PMID: 29580282
- CHI3L1 expression is a novel biomarker for the prognosis of gastric cancer and these findings have thus identified CHI3L1/CD44 axis as a vital pathway and potential therapeutic target in gastric cancer PMID: 30165890
- YKL-40 was highly elevated in patients with ESRD on HD, and dialysis reduced serum YKL-40 concentrations approximately one-sixth. YKL-40 measured after dialysis was independently associated with mortality in HD patients. PMID: 29357700
- Review/Meta-analysis: YKL-40 may be implicated in bronchial inflammation and remodeling in COPD and may be considered as a useful biomarker for COPD diagnosis and monitoring. PMID: 29430175
- YKL-40 is a glycoprotein - a potential marker for active inflammatory process - with proven predictive value in a number of diseases that evolve with inflammation, remodeling of the extracellular matrix, or development of fibrosis. PMID: 29400369
- TMEM219 plays a critical role in Chi3l1-induced IL-13Ralpha2 mediated signalling and tissue responses. PMID: 27629921
- Our present data reveal the crucial role of CHI3L1 in the formation of vasculogenic mimicry, which may contribute to tumour aggressiveness of cervical cancer PMID: 29452694
- there was a negative correlation between YKL-40 and TLR4 expression in chronic sinusitis patients with nasal polyps. YKL-40 and TLR4 interacted with each other to activate NF-kappaB and promote disease progression. PMID: 29921378
- CHI3L1 may be a previously unrecognized biomarker for diagnosing Gaucher Diseases (GD) and for evaluating the therapeutic effects of new GD drug. PMID: 29396296
- Study established a connection between the pretreated CHI3L1 and patients with esophageal squamous cell carcinoma (ESCC), and the serum CHI3L1 was primarily secreted by ESCC-surrounded macrophages. PMID: 29209110
- YKL-40 is expressed in cutaneous Squamous Cell Skin Cancer PMID: 30061245
- The G allele of CHI3L1 rs4950928 might be a protective factor against the development of asthma. PMID: 29233108
- This study suggests that CHI3L1 and CHI3L2 are associated with the progression of neurodegeneration in motor cortex and spinal cord of Amyotrophic Lateral Sclerosis patients. PMID: 28989002
- in neurodegenerative dementias, YKL-40 is a disease-specific marker of neuroinflammation showing its highest levels in prion diseases PMID: 29126445
- Serum IL-6, serum YKL-40, and plasma VEGF were significantly correlated with disease activity at baseline in early rheumatoid arthritis. PMID: 29336711
- high serum YKL-40 levels correlated with the severity of obstructive sleep apnea syndrome and might serve as a nonspecific biomarker for prediction and progression of the disease. PMID: 29028081
- YKL-40 could be considered as a useful biomarker of inflammation in psoriasis and is more sensitive than CRP or WBC. Increased YKL-40 may indicate psoriatic patients with a higher level of systemic inflammation, which may determine disease management. PMID: 28932021
- YKL-40 protein expression associated with severe lung function impairment and severe exacerbations in Asthma patients. PMID: 29025889
- Results suggest a potential role of chitinase 3 like 1 protein (CHI3L1) in angiogenesis in invasive ductal breast carcinoma (IDC) and may suggest its involvement in cancer progression. PMID: 29848684
- YKL-40 is a promising biomarker for evaluating polymyositis/dermatomyositis-associated interstitial lung disease activity/severity and predicting disease prognosis. PMID: 28711881
- Early-onset atopic dermatitis was associated with rs2303067 in SPINK5, which is involved in skin barrier functioning, and late-onset was associated with rs4950928 in CHI3L1, which is involved in the immune response. Future studies should examine the early- versus late-onset subgrouping more closely. PMID: 28681574
- YKL-40 may represent a novel biomarker for predicting hypertension risk in prehypertension population PMID: 28797750
- A high diagnostic sensitivity of YKL-40 in the early stages of the disease suggests the possibility of using this biomarker at an early diagnostic phase of patients with endometrial cancer. The patients with increased levels of YKL-40 before treatment are also at the higher risk of relapse. PMID: 28624692
- Serum YKL-40 was elevated only in atrial fibrllation and not in other supraventricular arrhythmias. PMID: 28639986
- YKL-40 is elevated in serum and bronchoalveolar lavage fluid of pulmonary alveolar proteinosis (PAP) patients, and may be of clinical utility to predict outcome in PAP PMID: 28569052
- strongly expressed in placenta percreta and correlated with extravillous trophoblast invasion PMID: 27977409
- YKL-40 was expressed by macrophages in liver tissue of NAFLD patients. PMID: 27739482
- The results of this study indicate that YKL-40 may contribute to decreased stability and increased permeability of BBB in AD patients PMID: 28697565
- YKL-40 is expressed by a subset of astrocytes in Alzheimer's disease and other tauopathies. PMID: 28599675
- This study has shown that YKL-40 serum level is increased in patients with atopic dermatitis and reflects the severity of symptoms. PMID: 28660216
- YKL-40 levels were found to be significantly higher in post-infectious bronchiolitis obliterans (PIBO) patients with exacerbation compared with that in bronchiolitis patients and showed a positive correlation with the severity of disease before diagnosis of PIBO. PMID: 28567534
- miR-24 serves as a molecular regulator in S. aureus-induced macrophage polarization through targeting of CHI3L1 and regulation of the MAPK pathway PMID: 28303416
- High YKL-40 expression is independently and markedly associated with worse overall survival in glioblastoma patients. PMID: 27090900
- Datashow that patients with YKL-40 overexpression had significantly shorter survival time than those with low YKL-40 expression. PMID: 28099248
- The level of serum YKL-40 is a significant and independent biomarker to predict the clinical outcome in large-artery atherosclerotic stroke. PMID: 27650381
- TrkB-containing exosomes play a key role in the control of glioblastoma progression and aggressiveness, as seen in a model of YKL-40-inactivated glioblastoma cells PMID: 27385098
- findings suggest that these pulmonary markers could be useful to assess CAP severity and, especially YKL-40 and CCL18 by helping predict CAP caused by atypical pathogens PMID: 29324810
- The present meta-analysis indicate that elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients. YKL-40 may serve as a promising predictive biomarker of prognosis of breast cancer PMID: 28036271
- YKL-40 induces IL-18 production in osteoblasts and thereby stimulates angiogenesis of endothelial progenitor cells through the suppression of miR-590-3p via the focal adhesion kinase (FAK)/PI3K/Akt signaling pathway. PMID: 28448439
- YKL-40 levels showed a positive correlation with blood neutrophil counts but no consistent relationships with clinical characteristics of relevance to continuous wheeze in preschool children PMID: 27732738
- Study suggests that YKL-40 is associated with hypertension incidence only among men. PMID: 27815265
- In HCT donors with YKL-40 plasma concentrations, a trend toward increased grade II-IV acute GvHD in recipients was observed with no significant associations with overall survival, treatment-related mortality or relapse PMID: 27427920
- Review of evidence for the role of YKL-40 in the diagnosis, prognosis and cause of cardiovascular and alcoholic liver disease. PMID: 27187575
- the level of CHI3L1 protein in the sera of patients with gastric or breast cancer was significantly elevated compared with those of healthy donors. M2 macrophage-secreted CHI3L1 promoted the metastasis of gastric and breast cancer cells in vitro and in vivo PMID: 28143526
- Besides being associated with tau pathology, CSF YKL-40 adds to the growing array of biomarkers reflecting distinct molecular brain mechanisms potentially useful for stratifying individuals for biomarker-guided, targeted anti-inflammatory therapies emerging from precision medicine. PMID: 28281838
- SNPs in CHI3L1 and cord blood YKL-40 were not associated with lung function measurements at 5 weeks and 6 years, respiratory symptoms in the first year, and allergic sensitisation at 6 years. Genetic variation in CHI3L1 might be related to the development of milder forms of asthma. PMID: 27193312
顯示更多
收起更多
-
相關疾病:
Asthma-related traits 7 (ASRT7); Schizophrenia (SCZD)
-
亞細胞定位:
Secreted, extracellular space. Cytoplasm. Cytoplasm, perinuclear region. Endoplasmic reticulum.
-
蛋白家族:
Glycosyl hydrolase 18 family
-
組織特異性:
Present in activated macrophages, articular chondrocytes, synovial cells as well as in liver. Very low or undetectable expression in non-inflammatory colon. Undetectable in muscle tissues, lung, pancreas, mononuclear cells, or fibroblasts.
-
數據庫鏈接:
Most popular with customers